Form 8-K - Current report:
SEC Accession No. 0001193125-26-401157
Filing Date
2026-09-24
Accepted
2026-09-24 17:11:07
Documents
13
Period of Report
2026-09-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d168737d8k.htm   iXBRL 8-K 34057
2 EX-99.1 d168737dex991.htm EX-99.1 22356
6 GRAPHIC g168737dsp006.jpg GRAPHIC 6245
  Complete submission text file 0001193125-26-401157.txt   190565

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acad-20260924.xsd EX-101.SCH 3193
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20260924_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20260924_pre.xml EX-101.PRE 11270
17 EXTRACTED XBRL INSTANCE DOCUMENT d168737d8k_htm.xml XML 3680
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 261405361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)